Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ischemic Heart Disease

Free Subscription 20.07.2026 1 AJR Am J Roentgenol 4 Am Heart J 2 Am J Cardiol 1 Angiology 1 Atherosclerosis 2 Can J Cardiol 1 Cardiovasc Res 2 Circ Res 4 Circulation 1 Clin Cardiol 2 Eur Heart J 1 Heart 6 J Am Coll Cardiol 2 J Cardiovasc Pharmacol 4 JAMA 4 Lancet 1 Mol Cell Biochem 6 N Engl J Med 5 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. XU C, Zou L, He S, Zhang T, et al
   Comparison of Super-Resolution Deep-Learning Reconstruction and Hybrid Iterative Reconstruction for Coronary Stent Assessment on CTA: A Prospective Multicenter Study.
   AJR Am J Roentgenol. 2026 Jul 15. doi: 10.2214/AJR.26.34957.
   PubMed         Abstract available
   
   

   
   Am Heart J

2. BERTOLET M, Triulzi DJ, Campbell-Lee S, Gordeuk VR, et al
   Design, rationale, and baseline patient characteristics for the Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange (SCD-CARRE) trial.
   Am Heart J. 2026 Jul 15:107542. doi: 10.1016/j.ahj.2026.107542.
   PubMed         Abstract available
   
   
3. OPOLSKI MP, Spiewak M, Machaj F, Borzuta H, et al
   Antegrade dissection and re-entry versus retrograde strategy in chronic total occlusion percutaneous coronary intervention: Rationale and design of the ADRENALINE randomized study.
   Am Heart J. 2026 Jul 11:107538. doi: 10.1016/j.ahj.2026.107538.
   PubMed         Abstract available
   
   
4. GIANNAKOPOULOU SP, Chrysohoou C, Antonopoulou S, Barkas F, et al
   Integrative assessment of high-sensitivity C-reactive protein and lipid levels in predicting 20-year atherosclerotic cardiovascular disease risk, in a Mediterranean population: The ATTICA study (2002-2022).
   Am Heart J. 2026 Jul 11:107540. doi: 10.1016/j.ahj.2026.107540.
   PubMed         Abstract available
   
   
5. SCHEIER TC, Gerstein HC, Mosterd A, Qilong Y, et al
   Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: a descriptive compatibility analysis.
   Am Heart J. 2026 Jul 11:107539. doi: 10.1016/j.ahj.2026.107539.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

6. CHOI SH, Lee KJ, Jang JH, Baek YS, et al
   Prognostic implications of high platelet reactivity according to DAPT score after drug-eluting stent implantation: Insight from the PTRG-DES consortium.
   Am J Cardiol. 2026 Jul 16:S0002-9149(26)00452.
   PubMed         Abstract available
   
   
7. WANG J
   Clarifying analysis inconsistencies in a study of GLP-1RAs and cardiovascular outcomes in non-diabetic patients with atherosclerotic disease and obesity.
   Am J Cardiol. 2026 Jul 12:S0002-9149(26)00451.
   PubMed        
   
   

   
   Angiology

8. YU C, Chen Z, Zhu Y
   Recent Advances in the Relationship Between Thyroid Hormone Sensitivity and Cardiovascular Diseases: A Narrative Review.
   Angiology. 2026 Jul 17:33197261467578. doi: 10.1177/00033197261467578.
   PubMed         Abstract available
   
   

   
   Atherosclerosis

9. LIAO CC, Hu WC, Yang SF, Li JM, et al
   Genome-wide cross-trait analysis reveals immunogenetic pleiotropy between autoimmune diseases and myocardial infarction and prioritizes therapeutic targets.
   Atherosclerosis. 2026;420:121849.
   PubMed         Abstract available
   
   

   
   Can J Cardiol

10. AYTEKIN A, Voll F, Simonetti F, Blum E, et al
    Clinical and Angiographic Outcomes Following Percutaneous Treatment of Chronic Totally Occluded Versus Non-Totally Occluded Coronary Vessels.
    Can J Cardiol. 2026;42:1490-1501.
    PubMed         Abstract available
    
    
11. RAZAVI AA, Sallam A, Lim B, Sharew B, et al
    Reevaluating Internal Thoracic Artery Use in Octogenarians Undergoing Multivessel Coronary Artery Bypass Grafting.
    Can J Cardiol. 2026;42:1665-1672.
    PubMed         Abstract available
    
    

    
    Cardiovasc Res

12. ZHAO J, Ruan Y, Chen Y, Chen Q, et al
    Urea cycle fumarate limits fibrosis post-myocardial infarction by reducing fibroblast mitochondrial adenosine triphosphate production.
    Cardiovasc Res. 2026;122:1359-1373.
    PubMed         Abstract available
    
    

    
    Circ Res

13. ZHOU R, Cai D, Chen SY
    Immune Targeting of Oligomeric Ninjurin 1 Protects Against Myocardial Infarction in Mice.
    Circ Res. 2026 Jul 15:10.1161/CIRCRESAHA.126.328766.
    PubMed        
    
    
14. BAI Y, Zhao T, Wang Q, Zhang R, et al
    NUAK1 Inhibition Alleviates Ischemia-Reperfusion Injury via SYNE1-YAP1.
    Circ Res. 2026;139:e328256.
    PubMed         Abstract available
    
    

    
    Circulation

15. JOYNT MADDOX KE
    An Integrated Ecosystem for Cardiovascular Science and Health.
    Circulation. 2026;154:85-87.
    PubMed        
    
    
16. GENTILE F, Emdin M, Clemente A
    Response by Gentile et al to Letters Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e22-e23.
    PubMed        
    
    
17. HAN QJ, Stefanescu Schmidt AC, DeFaria Yeh D
    Letter by Han et al Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e18-e19.
    PubMed        
    
    
18. LI Q, Zhang P
    Letter by Li and Zhang Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults".
    Circulation. 2026;154:e20-e21.
    PubMed        
    
    

    
    Clin Cardiol

19. ARNOLD R, Gervasoni R, Ledermann B, Moulis L, et al
    Long-Term Follow-up After Percutaneous Coronary Interventions for Chronic Total Occlusions.
    Clin Cardiol. 2026;49:e70414.
    PubMed         Abstract available
    
    

    
    Eur Heart J

20. QI Y, Li J, Yang Z, Liu J, et al
    Cardiovascular disease in China: epidemiological evolution and implications.
    Eur Heart J. 2026 Mar 25:ehaf1121. doi: 10.1093/eurheartj/ehaf1121.
    PubMed         Abstract available
    
    
21. RAVEENDRA K, Gale CP
    Translating evidence of beta-blocker effectiveness following myocardial infarction.
    Eur Heart J. 2026 Jul 17:ehag506. doi: 10.1093.
    PubMed        
    
    

    
    Heart

22. DRISCOLL TJ, Black S, Davies G, Gale CP, et al
    Prehospital 12-lead ECG and outcomes in acute coronary syndrome.
    Heart. 2026;112:847-854.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

23. SALAZAR JW, Nakasuka K, Connolly AJ, Moffatt E, et al
    Sudden Cardiac Death and its Relation to Previously Diagnosed or Occult Cardiac Disease at Autopsy.
    J Am Coll Cardiol. 2026;88:150-166.
    PubMed         Abstract available
    
    
24. LUO H, Chen R, Kan H
    Beyond PM(2.5) Mass: Constituent-Specific Cardiovascular Risks and Implications for Air Pollution Control.
    J Am Coll Cardiol. 2026 Jul 3:S0735-1097(26)06757.
    PubMed        
    
    
25. GALLI M, Capodanno D, Berg JT, Cavallari LH, et al
    Aspirin Withdrawal in Patients With Coronary Artery Disease.
    J Am Coll Cardiol. 2026 Jul 8:S0735-1097(26)06769.
    PubMed         Abstract available
    
    
26. RIKHI R, Chen H, Mirzai S, Bhatia HS, et al
    The Role of Coronary Artery Calcium in Statin Eligibility Based on the American Heart Association's PREVENT Calculator: Insights From MESA.
    J Am Coll Cardiol. 2026 Jul 7:S0735-1097(26)06707.
    PubMed         Abstract available
    
    
27. WANG W, Liu H, Li Q, Dou Y, et al
    Long-Term Exposure to PM(2.5) Constituents and Coronary Heart Disease Risk in China.
    J Am Coll Cardiol. 2026 Jul 2:S0735-1097(26)06655.
    PubMed         Abstract available
    
    
28. DHARMAKUMAR R, Youssef K
    Cardiac MRI of Chronic Myocardial Infarction: Emergence of a New Era?
    J Am Coll Cardiol. 2026 Jul 7:S0735-1097(26)06758.
    PubMed        
    
    

    
    J Cardiovasc Pharmacol

29. PUCHONGMART C, Rodriguez CC, Soliman D, Shotelersuk V, et al
    Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier.
    J Cardiovasc Pharmacol. 2026 Jul 6. doi: 10.1097/FJC.0000000000001855.
    PubMed         Abstract available
    
    
30. ZHENG W, Zhou Y, Ye B, Hu S, et al
    SGLT2 Inhibitors Attenuate Neutrophil-Mediated Endothelial Injury in Coronary Artery Disease With Type 2 Diabetes Mellitus Through a GREM1-Associated Smad Signaling Axis.
    J Cardiovasc Pharmacol. 2026;88:25-35.
    PubMed         Abstract available
    
    

    
    JAMA

31. YUAN J, Jiang X, Lu ZK
    Lead Exposure and the Coronary Heart Disease Epidemic.
    JAMA. 2026 Jul 16. doi: 10.1001/jama.2026.9341.
    PubMed        
    
    
32. LANPHEAR BP
    Lead Exposure and the Coronary Heart Disease Epidemic-Reply.
    JAMA. 2026 Jul 16. doi: 10.1001/jama.2026.9344.
    PubMed        
    
    
33. EINSTEIN AJ, Paez D
    Radiation Dose in Coronary Artery Disease Diagnostic Imaging-Reply.
    JAMA. 2026 Jul 13. doi: 10.1001/jama.2026.8929.
    PubMed        
    
    
34. LI S, Jiang R
    Radiation Dose in Coronary Artery Disease Diagnostic Imaging.
    JAMA. 2026 Jul 13. doi: 10.1001/jama.2026.8926.
    PubMed        
    
    

    
    Lancet

35. ZHU Y, Gaudino M, Zhao Q
    Physiology-guided coronary artery bypass grafting in valve surgery - Authors' reply.
    Lancet. 2026;408:218.
    PubMed        
    
    
36. MAGOULIOTIS DE, Sicouri S, Ramlawi B
    Physiology-guided coronary artery bypass grafting in valve surgery.
    Lancet. 2026;408:217-218.
    PubMed        
    
    
37. LIP GYH, Kuzma L
    Combination antithrombotic therapy in atrial fibrillation after coronary interventions: shorter duration, more safety?
    Lancet. 2026 Jul 15:S0140-6736(26)00747-6. doi: 10.1016/S0140-6736(26)00747.
    PubMed        
    
    
38. SOTOMI Y, Kozuma K, Higuchi Y, Nakazawa G, et al
    1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.
    Lancet. 2026 Jul 15:S0140-6736(26)00665-3. doi: 10.1016/S0140-6736(26)00665.
    PubMed         Abstract available
    
    

    
    Mol Cell Biochem

39. HAN S, Li W, Huang Y, Xu Y, et al
    RPS5 modulates inflammatory response and angiogenesis in coronary heart disease through NF-kappaB signaling activation.
    Mol Cell Biochem. 2026 Jul 13. doi: 10.1007/s11010-026-05636.
    PubMed         Abstract available
    
    

    
    N Engl J Med

40. PARK KW, Kang J
    Balancing the Scales - Extended DAPT in Coronary Artery Disease.
    N Engl J Med. 2026;395:304-305.
    PubMed        
    
    
41. YAMANOUCHI M, Tominaga N, Yonaha T
    Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
    N Engl J Med. 2026;395:311.
    PubMed        
    
    
42. ZHANG Z, He S
    Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
    N Engl J Med. 2026;395:311.
    PubMed        
    
    
43. MARCHINI M, Trezzi M
    Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
    N Engl J Med. 2026;395:311-312.
    PubMed        
    
    
44. LOK CE, Polkinghorne KR, Tomlinson G
    Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis. Reply.
    N Engl J Med. 2026;395:312.
    PubMed        
    
    
45. TIAN J, Wang Z, Wang Y, Wang F, et al
    Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease.
    N Engl J Med. 2026;395:233-242.
    PubMed         Abstract available
    
    

    
    PLoS One

46. REVATHI CK, Santhi H
    A novel dynamic Optuna hybrid Harris Hawks Optimization approach for classification of CAD.
    PLoS One. 2026;21:e0353605.
    PubMed         Abstract available
    
    
47. ZHU X, Wu Q, Kang Z, Chen S, et al
    Blood urea nitrogen to albumin ratio and mortality in critically ill patients with cardiogenic shock.
    PLoS One. 2026;21:e0352659.
    PubMed         Abstract available
    
    
48. SVENDSEN CD, Nielsen R, Larsen TH, Kuiper KKJ, et al
    The oral and lower airway microbiota and coronary heart disease in COPD patients and controls.
    PLoS One. 2026;21:e0353738.
    PubMed         Abstract available
    
    
49. JARAB AS, Al-Qerem W, Mansour R, Jarab H, et al
    Factors associated with low-density lipoprotein control in outpatients with myocardial infarction: A hospital-based study.
    PLoS One. 2026;21:e0353521.
    PubMed         Abstract available
    
    
50. JANG MH, Park S, Ann SH, Kim YG, et al
    Degree of hypertension and subclinical coronary atherosclerosis in asymptomatic individuals without cardiovascular disease.
    PLoS One. 2026;21:e0353359.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum